Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan D Choi

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2018
Immunotherapy for Glioblastoma: Adoptive T-cell StrategiesBryan D Choi, Marcela V Maus, Carl H June, et al.
Drugs of the Future|February 10, 2015
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolyticPatrick C Gedeon, Bryan D Choi, John H Sampson, et al.
Neurosurgical Focus|June 2, 2018
Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeonsBryan D Choi, William T Curry, Bob S Carter, et al.
Current Opinion in Virology|April 8, 2015
Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infectionChristopher A Alvarez-Breckenridge, Bryan D Choi, Carter M Suryadevara, et al.
Current Drug Discovery Technologies|February 21, 2012
Immunotherapy with tumor vaccines for the treatment of malignant gliomasDivya Ajay, Luis Sanchez-Perez, Bryan D Choi, et al.
Spine|November 24, 2016
Effect of Immunotherapy Status on Outcomes in Patients With Metastatic Melanoma to the SpineGanesh M Shankar, Bryan D Choi, Benjamin L Grannan, et al.
Journal of Neurosurgery|April 16, 2013
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a reviewTiffany R Hodges, Bryan D Choi, Darell D Bigner, et al.
Current Treatment Options in Oncology|April 22, 2024
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?Alexander F Wang, Brian Hsueh, Bryan D Choi, et al.
Journal of Neurosurgery|December 24, 2013
Impact of PhD training on scholarship in a neurosurgical careerBryan D Choi, Michael R DeLong, David M DeLong, et al.
Oncoimmunology|January 30, 2014
Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibodyBryan D Choi, Patrick C Gedeon, Luis Sanchez-Perez, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2018
Immunotherapy for Glioblastoma: Adoptive T-cell StrategiesBryan D Choi, Marcela V Maus, Carl H June, et al.
Drugs of the Future|February 10, 2015
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolyticPatrick C Gedeon, Bryan D Choi, John H Sampson, et al.
Neurosurgical Focus|June 2, 2018
Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeonsBryan D Choi, William T Curry, Bob S Carter, et al.
Current Opinion in Virology|April 8, 2015
Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infectionChristopher A Alvarez-Breckenridge, Bryan D Choi, Carter M Suryadevara, et al.
Current Drug Discovery Technologies|February 21, 2012
Immunotherapy with tumor vaccines for the treatment of malignant gliomasDivya Ajay, Luis Sanchez-Perez, Bryan D Choi, et al.
Spine|November 24, 2016
Effect of Immunotherapy Status on Outcomes in Patients With Metastatic Melanoma to the SpineGanesh M Shankar, Bryan D Choi, Benjamin L Grannan, et al.
Journal of Neurosurgery|April 16, 2013
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a reviewTiffany R Hodges, Bryan D Choi, Darell D Bigner, et al.
Current Treatment Options in Oncology|April 22, 2024
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?Alexander F Wang, Brian Hsueh, Bryan D Choi, et al.
Journal of Neurosurgery|December 24, 2013
Impact of PhD training on scholarship in a neurosurgical careerBryan D Choi, Michael R DeLong, David M DeLong, et al.
Oncoimmunology|January 30, 2014
Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibodyBryan D Choi, Patrick C Gedeon, Luis Sanchez-Perez, et al.
Pageof 13